Hyderabad-based investment and scaling platform Anthill Ventures has partnered with HealthCare Global Enterprises to launch Lumos, a market access program for HealthTech startups in India.
Lumos is a 12-month program designed for HealthTech startups with disruptive solutions and technologies within the core businesses of HCG which include oncology, fertility, precision medicine, genomics, research and diagnostics, as well as emerging areas across the healthcare ecosystem.
The idea is to bring high-quality cancer care solutions from across the globe and make them accessible to HCG’s patients across India.
For HealthTech startups, the program will give them access to new customers through Anthill and HCG’s networks, business mentoring and support with a platform to showcase their products to the right market and an opportunity to work on pilot projects through partnerships with corporates. The startups also stand a chance to receive funding of up to $1 million.
“At Anthill Ventures we source, invest in, and help scale startups, in addition to syndicating capital. Our core mantra is to 'scale with speed', and our investments, programs and platforms have been designed to drive rapid sustainable growth for companies. We are excited to partner with HCG who bring a depth of domain specialization and scale that is rare to find. Through Lumos, we are looking for the world's most innovative and disruptive healthcare technology startups that are ready to scale with speed,” Bharani Setlur, Partner at Anthill Ventures and Program Director, Lumos said.
Anthill Ventures is a global speed scaling ecosystem for startups, headquartered out of T-Hub in Hyderabad. It has a dedicated team spread across Hyderabad, Mumbai, Bangalore and Singapore that enables the startups with an extensive global network of Venture Capitalists, Private Equity firms, Family Offices, and Luminaries in the technology industry.
Applications for Lumos are now open and close on October 15. The program launches on November 15. Startups looking to apply need to have breakthrough solutions, technology, and innovation for the healthcare industry, an established a product market fit with customers and a clear growth strategy that Lumos can help them execute.
Dr B.S. Ajaikumar, Chairman and CEO of the Healthcare Global Enterprises said, “We have been pioneers in bringing leading technology for cancer care to patients. The future of healthcare is going to be driven by innovative solutions for complex clinical problems being solved through technology. Lumos brings about an opportunity to create disruption in multiple areas, including novel treatment ideas, enhanced patient experience as well as efficiency of healthcare operations to name a few. Through Lumos, HCG hopes to connect with startups to mentor and support them. Anthill was the right partner for us as they came equipped with the right expertise in Speed Scaling and networking. They also shared with us the enthusiasm and the passion to work in the healthcare segment.